Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review

Bavarian Nordic AS (BAVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company that develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. The company develops its products using poxvirus-based technology platforms including modified vaccinia ankara bavarian nordic (MVA-BN). Its pipeline products are intended for the treatment of smallpox, prostate cancer, bladder cancer, solid tumors, chronic HPV infection, marburg and ebola infections and others. Bavarian Nordic has collaboration with US government and various institutes, to develop its product candidates for the treatment of cancer and infectious diseases. It has a presence in the US, Denmark and Germany. Bavarian Nordic is headquartered in Kvistgaard, Denmark.

Bavarian Nordic AS Key Recent Developments

Jun 25,2019: Bavarian Nordic applauds reauthorization of key U.S. biodefense programs
May 22,2019: Bavarian Nordic reports interim results for the first three months of 2019
Mar 21,2019: Bavarian Nordic announces annual report 2018
Nov 09,2018: Bavarian Nordic announces interim results for the first nine months of 2018
Nov 05,2018: APC Partners with Bavarian Nordic to Build Biologics Plant in Dublin, Ireland

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
Section 1 - About the Company
Bavarian Nordic A/S - Key Facts
Bavarian Nordic A/S - Key Employees
Bavarian Nordic A/S - Key Employee Biographies
Bavarian Nordic A/S - Major Products and Services
Bavarian Nordic A/S - History
Bavarian Nordic A/S - Company Statement
Bavarian Nordic A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Bavarian Nordic A/S - Business Description
Geographical Segment: Canada
Performance
Geographical Segment: Other Geographic Markets
Performance
Geographical Segment: The Netherlands
Performance
Geographical Segment: The US
Performance
Bavarian Nordic A/S - SWOT Analysis
SWOT Analysis - Overview
Bavarian Nordic A/S - Strengths
Bavarian Nordic A/S - Weaknesses
Bavarian Nordic A/S - Opportunities
Bavarian Nordic A/S - Threats
Bavarian Nordic A/S - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences, Power Financial Deals and Alliances
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bavarian Nordic A/S, Recent Deals Summary
Section 5 Companys Recent Developments
Jun 25, 2019: Bavarian Nordic applauds reauthorization of key U.S. biodefense programs
May 22, 2019: Bavarian Nordic reports interim results for the first three months of 2019
Mar 21, 2019: Bavarian Nordic announces annual report 2018
Nov 09, 2018: Bavarian Nordic announces interim results for the first nine months of 2018
Nov 05, 2018: APC Partners with Bavarian Nordic to Build Biologics Plant in Dublin, Ireland
Nov 01, 2018: Henrik Juuel joins Bavarian Nordic as chief financial officer
Aug 16, 2018: Bavarian Nordic announces first half 2018 results
Aug 09, 2018: Bavarian Nordic granted EUR 30 million loan from The European Investment Bank
May 31, 2018: Bavarian Nordic Appoints Henrik Juuel As Chief Financial Officer
May 24, 2018: Bavarian Nordic Announces Interim Results for the First Three Months of 2018
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Bavarian Nordic A/S, Key Facts
Bavarian Nordic A/S, Key Employees
Bavarian Nordic A/S, Key Employee Biographies
Bavarian Nordic A/S, Major Products and Services
Bavarian Nordic A/S, History
Bavarian Nordic A/S, Other Locations
Bavarian Nordic A/S, Subsidiaries
Bavarian Nordic A/S, Key Competitors
Bavarian Nordic A/S, Ratios based on current share price
Bavarian Nordic A/S, Annual Ratios
Bavarian Nordic A/S, Annual Ratios (Cont...1)
Bavarian Nordic A/S, Annual Ratios (Cont...2)
Bavarian Nordic A/S, Interim Ratios
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bavarian Nordic A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Bavarian Nordic A/S, Performance Chart (2014 - 2018)
Bavarian Nordic A/S, Ratio Charts
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Bavarian Nordic A/S (BAVA) - Financial and Strategic SWOT Analysis Review

Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company that develops, manufactures and commercializes cancer immunotherapies and vaccines for infectious diseases. The company develops its products using its poxvirus-based technology

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available